Data Characteristics in Preclinical Safety Assessment
Preclinical safety assessment data originates primarily from experimental reports, research papers, registration dossiers, toxicology databases, and pharmacokinetic reports. This data combines structured elements (e.g., compound properties, dosages, observed metric values) and unstructured elements (e.g., experimental method descriptions, pathological diagnoses, expert evaluation conclusions). Update frequency is low, mainly occurring during new compound development or regulatory changes. Document structures are complex, containing extensive specialized terminology, abbreviations, and diagrams. Field units vary; for example, compound concentrations may use μM or mg/kg, and toxicity indicators like LD50 or NOAEL often include time points (e.g., 24 hours, 7 days) and animal models (e.g., Sprague-Dawley rats).
Constraints Imposed by Data Characteristics on Model Integration and Configuration
The diverse data sources and complex document structures in preclinical safety assessment necessitate strong multimodal processing capabilities and deep semantic understanding from the model to accurately extract key information. The low update frequency means knowledge base construction must prioritize data authority and long-term validity, avoiding frequent incremental updates. The abundance of specialized terminology and abbreviations requires the embedding model to effectively capture semantic relationships between domain-specific words, reducing recall bias caused by rare terms. The mixed structured and unstructured data format poses challenges for chunking strategies, requiring a balance between the precision of numerical data and the contextual completeness of textual data. Furthermore, diverse field units and dosage descriptions require the model to perform unit conversions or recognition during queries to provide accurate comparisons and recommendations.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Length) | 800–1200 characters (characters) | Balances the context of specialized terms with the information density of individual chunks, preventing semantic loss from excessive splitting. |
Chunk Overlap Length (Chunk Overlap Length) | 100–150 characters (characters) | Ensures necessary contextual continuity between paragraphs, especially when describing experimental methods or results. |
Recall count (Recall Count) | Top 10–15 entries (top 10–15 entries) | Preclinical safety assessment reports are information-dense; increasing recall count improves the hit rate of critical information. |
Similarity threshold (Similarity Threshold) | Calibrate based on actual measurements | Requires adjustment based on specific toxicology data and query types to balance relevance and precision. |
Rerank result count (Reranked Return Count) | 5–8 entries (5–8 entries) | Reranked models more accurately filter the most relevant preclinical safety assessment information for a query. |
Max Tokens | 4096 Tokens | Accommodates detailed experimental descriptions and complex toxicology reports, ensuring complete contextual input. |
Three Common Pitfalls
- Irrelevant compounds or experimental data appear in query results: This typically occurs when the
Similarity threshold(Similarity Threshold) is set too high, leading to a narrow recall scope that fails to capture semantically distant but actually relevant preclinical safety assessment information. - Model output for dosage or unit information is inconsistent: This may stem from inconsistent unit labeling in the original data or a
Chunk size(Chunk Length) that is too short, causing the model to lose contextual information linking units during processing. - Access to the publishing channel is restricted, preventing external users from accessing it: This happens when the
PUBLIC_URLenvironment variable of the FastGPT deployment environment is not configured correctly, resulting in the generation of internal-only links.
How to Verify Configuration
- Submit a series of queries containing specialized terminology and abbreviations. Observe if the model accurately identifies and returns relevant preclinical safety assessment data. Check if key fields in the returned results (e.g.,
Compound ID,Dosage,Toxicity Endpoint) are correct. - Test preclinical safety assessment queries of varying complexity, such as those involving multi-stage experimental result comparisons or pharmacokinetic parameter analysis. Evaluate the completeness and logical coherence of the information returned by the model.
- Simulate user inquiries about specific compound toxicology data. Check if the model's output includes correct units and numerical values. Compare these with the original reports to confirm accuracy.
The values provided are common starting points and should be measured against specific samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.